| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/17/2008 | CN101267824A Dosage forms and methods of treatment using a tyrosine kinase inhibitor |
| 09/17/2008 | CN101267821A Synergistic modulation of FLT3 kinase using a FLT3 inhibitor and a farnesyl transferase inhibitor |
| 09/17/2008 | CN101267816A Methods of treatment using hydroquinone ansamycins |
| 09/17/2008 | CN101267813A Substituted propanamide derivative and pharmaceutical composition containing the same |
| 09/17/2008 | CN101267812A Hydrazone agents to treat cutaneous lesions |
| 09/17/2008 | CN101265482A Recombination tumor chalone-tumor putrescence factor secretion type eukaryon expression vector and its preparation method and use |
| 09/17/2008 | CN101265302A Panax japonicus polysaccharides, preparation method and use thereof |
| 09/17/2008 | CN101265301A Panax japonicus polysaccharides, preparation method and use thereof |
| 09/17/2008 | CN101265300A Small molecule recombination toxin GnRH-luffinS2 fusion albumen and its preparation and application |
| 09/17/2008 | CN101265298A Endothelium chalone mutant containing non-natural amino acid and derivatives thereof |
| 09/17/2008 | CN101265290A Peptide containing tryptophyl-lysyl(arginyl) fragment and anticancer use thereof |
| 09/17/2008 | CN101265285A Immunostimulatory nucleic acid molecules |
| 09/17/2008 | CN101265284A Method for synthesizing clofarabine |
| 09/17/2008 | CN101265275A Diethyl 4-{6-[5-(2-chloro-6-methylanilinoformacyl)-thiazolyl-2-amino]-2-methylpyrimidin-4}-piperazin-1-phosphate |
| 09/17/2008 | CN101265274A Pyrimidinthiazolamine derivatives, and preparation method, medicament composition and use thereof |
| 09/17/2008 | CN101265259A Novel IDO inhibitor and its usage method |
| 09/17/2008 | CN101265254A Novel IDO inhibitor and its usage method |
| 09/17/2008 | CN101265249A 4-position carbonyl nitrogen-containing derivative of 6-methoxy-4',7-dihydroxyisoflavone and medical use thereof |
| 09/17/2008 | CN101265248A Cembrene lactone type diterpenoid lobophilides A and B, and preparation method and use thereof |
| 09/17/2008 | CN101265243A Method for refining docetaxel |
| 09/17/2008 | CN101265233A Radiation and chemotherapy sensitizing agent-glucosamine glycididazole and preparation method thereof |
| 09/17/2008 | CN101265212A Antineoplastic alkanna tinctoria ketoximes derivatives |
| 09/17/2008 | CN101264330A Macromolecule material drug carrier system for targeted therapy and preparation and application thereof |
| 09/17/2008 | CN101264328A Anticancer sustained-release gel injection containing stines medicine |
| 09/17/2008 | CN101264325A RS7 antibodies |
| 09/17/2008 | CN101264319A Preparation of exenatide freeze-drying preparation |
| 09/17/2008 | CN101264311A Natural pharmaceutical composition, its preparation and its attenuation synergistic use in cancer radiotherapy and chemotherapy |
| 09/17/2008 | CN101264301A Chinese medicinal composition for treating esophageal cancer and preparation thereof |
| 09/17/2008 | CN101264286A Chinese medicinal composition for treating brain cancer and preparation thereof |
| 09/17/2008 | CN101264285A Chinese medicine assembly for treating cervical cancer and preparation thereof |
| 09/17/2008 | CN101264279A Chinese medicinal composition for treating common cancer and producing method thereof |
| 09/17/2008 | CN101264278A Chinese medicinal composition for treating leukemia and producing method thereof |
| 09/17/2008 | CN101264272A Chinese medicinal composition for treating malignant lymphoma and preparation thereof |
| 09/17/2008 | CN101264271A Chinese medicinal composition for treating cancer of pancreas and preparation thereof |
| 09/17/2008 | CN101264268A Proprietary Chinese medicine for treating tumor |
| 09/17/2008 | CN101264267A Anti-tumor and anti-cancer medicine and preparation thereof |
| 09/17/2008 | CN101264222A Chinese medicinal composition for treating breast cancer |
| 09/17/2008 | CN101264221A Chinese medicinal composition for treating colorectal cancer and preparation thereof |
| 09/17/2008 | CN101264192A Chinese medicinal composition for treating ovarian cancer and preparation thereof |
| 09/17/2008 | CN101264178A Preparation of Chinese medicine lotion for treating malignant skin ulcer |
| 09/17/2008 | CN101264175A Chinese medicinal composition for treating stomach cancer and preparation thereof |
| 09/17/2008 | CN101264164A Medicinal composition for treating tumor and preparation thereof |
| 09/17/2008 | CN101264127A Sophora alopecuroids total alkaloid powder injection and preparation thereof |
| 09/17/2008 | CN101264113A Acanthopanax senticosus effective component and preparation and application |
| 09/17/2008 | CN101264111A Application of water chestnut volatile oil in preparing tumor inhibitory medicaments |
| 09/17/2008 | CN101264110A Water chestnut polysaccharide and its extracting method and pharmaceutical use |
| 09/17/2008 | CN101264069A Application of resveratrol derivative in preparing medicine for treating disease relative to immune |
| 09/17/2008 | CN101264064A Vinpocetine freeze-dried powder for injection and preparation thereof |
| 09/17/2008 | CN101264061A Super-critical anti-solvent preparation for water-soluble nano camptothecin powder |
| 09/17/2008 | CN101264056A Epirubicin hydrochloride liposome and preparation thereof |
| 09/17/2008 | CN101264052A Compound anticancer sustained-release agent containing clofarabine |
| 09/17/2008 | CN101263841A Functional health care dairy products |
| 09/17/2008 | CN100419079C Compositions and methods for therapy and diagnosis of prostate cancer |
| 09/17/2008 | CN100419078C Expression method of glucosal related protein and application thereof |
| 09/17/2008 | CN100418981C Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 09/17/2008 | CN100418971C Heteroryl-fused pyrimidinyl compounds as anticancer agents |
| 09/17/2008 | CN100418970C Method for preparing polymorphism of irinotecan hydrochloride |
| 09/17/2008 | CN100418967C Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 09/17/2008 | CN100418965C Imidazopyridine derivatives |
| 09/17/2008 | CN100418958C Taxane derivatives and processes for the preparation thereof |
| 09/17/2008 | CN100418955C Novel Benzo-fused heterocycles |
| 09/17/2008 | CN100418585C Stable radiopharmaceutical compositions and methods for preparation |
| 09/17/2008 | CN100418577C Hpv-16 and -18 l1 vlp vaccine. |
| 09/17/2008 | CN100418576C Subcutaneously-administered ganglioside-based vaccine compositions |
| 09/17/2008 | CN100418574C chromatin peptide for blocking human HIF-1 alpha gene and regulating network downstream related gene |
| 09/17/2008 | CN100418539C Liquid polysaccharide, glycan nano-selenium, prepn. method and storage method thereof |
| 09/17/2008 | CN100418532C Use of NF-kB inhibitor for treating several diseases |
| 09/17/2008 | CN100418531C Therapeutic agents comprising an anti-angiogenic agent in combination with an src-inhibitor and their therapeutic use |
| 09/17/2008 | CN100418520C Apoferritin ¿Cplatinum anticancer drug composition and preparation method thereof |
| 09/17/2008 | CN100418430C Biological health tea |
| 09/16/2008 | US7425637 mitogen-activated protein/extracellular signal-regulated (MAP/ERK)Kinase pathways; 6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethoxy)-amide; hyperproliferative diseases; anticarcinogenic and antiinflammatory agent |
| 09/16/2008 | US7425636 2-amino-5phenyl-(1,3,4)thiodiazoline derivatives; antitumor, anticarcinogenic agent; transcription factor STAT6 and integrin antagonist; breast, gastric, ovarian, colon, lung, brain, hematological, urinary or genital, bladder, prostatic, renal, pancreatic, uterine cancers, skin, hepatic carcinoma |
| 09/16/2008 | US7425623 Binding to surface of tumor cell; bacteriophage separation; in situ diagnosis |
| 09/16/2008 | US7425610 Expression vector comprising nucleotide sequences coding novel receptor protein for use in prevention and treatment of cell proliferative and autoimmune disorders |
| 09/16/2008 | US7425606 Identifying cryptic epitopes comprising amino acid sequences of tumor antigen for diagnosis and treatment of viral and cancer disorder; viricides; antitumor agents |
| 09/16/2008 | US7425567 Inhibitor of phosphodiesterase enzyme, 2-(4-(3-cyclopentyloxy-4-difluoromethoxyphenyl)-4-cyanopiperidin-1-yl)acetic acid monohydrate; treating inflammatory diseases, diabetics, allergic diseases, autoimmune diseases, ocular diseases, osteoporosis, Parkinson's disease, dementia; chemical intermediates |
| 09/16/2008 | US7425566 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them |
| 09/16/2008 | US7425564 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus prolifertor receptor and medicinal composition containing the same |
| 09/16/2008 | US7425560 Thioxanthine derivatives as myeloperoxidase inhibitors |
| 09/16/2008 | US7425555 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 09/16/2008 | US7425337 Alphavirus replicon vector systems |
| 09/16/2008 | US7425334 immunization of non-human animals to generate polyclonal antibodies against Nogo proteins, comprising administering an immunogenic protein that is free of all central nervous system myelin and recovering polyclonal antibodies from the animal |
| 09/16/2008 | US7425331 Protein A methods of use |
| 09/16/2008 | US7425328 Comprises immunoglobulin which binds tissue factor and prevents blood coagulation for use as tool in treatment of thrombosis and thromboembolic disorders |
| 09/16/2008 | US7425325 binding ligands and proteins comprising amino acid sequences, having high specificity for the receptor zcytor17, used to induce proinflammatory cytokine production, for stimulating the immune system and proliferation and/or development of hematopoietic cells in vitro and in vivo; antibodies |
| 09/16/2008 | US7425317 Diagnosis, therapy of tumors, cancer |
| 09/16/2008 | CA2515338C Inhibitors of histone deacetylase |
| 09/16/2008 | CA2505128C Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 09/16/2008 | CA2427221C Process and intermediates for preparing anti-cancer compounds |
| 09/16/2008 | CA2379557C Arylsulphonamide-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 09/16/2008 | CA2358498C The preparation and use of radium-223 to target calcified tissues for pain palliation, bone cancer therapy, and bone surface conditioning |
| 09/16/2008 | CA2339290C Reaction products of hyaluronic acid and natural amino acids and their use in cosmetic and pharmaceutical compositions |
| 09/16/2008 | CA2337152C Pharmaceutical composition intended in particular for the prevention and the treatment of radiomucositis and chemomucositis |
| 09/16/2008 | CA2294095C Synergistically acting compositions for selectively combating tumor tissue |
| 09/16/2008 | CA2277757C Modified tumor necrosis factor |
| 09/16/2008 | CA2239519C Specific binding members for human carcinoembryonic antigen, materials and methods |
| 09/16/2008 | CA2223910C Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (nhe), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the nhe-inhibitory efficacy of compounds |
| 09/16/2008 | CA2202470C Intracellular isoform of the interleukin-1-receptor antagonist |
| 09/16/2008 | CA2188872C Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods of use |
| 09/16/2008 | CA2182228C Codrugs as a method of controlled drug delivery |